Table 1.
Baseline Characteristics of Study Patients Infected with COVID-19
| Characteristics | No. (%) |
p Value | ||
|---|---|---|---|---|
| Total (n = 46) | Adolescents (n = 14) | Young Adults (n = 32) | ||
| Exposure types | 0.58 | |||
| Resid in Wuhan | 19 (41.3) | 7 (50.0) | 12 (37.5) | |
| Travel to Wuhan | 3 (6.5) | 2 (14.3) | 1 (3.1) | |
| Contact with confirmed cases | 22 (47.8) | 5 (35.7) | 17 (53.1) | |
| None | 2 (4.4) | 0 (0.0) | 2 (6.3) | |
| Gender | 0.93 | |||
| Male | 24 (52.2) | 7 (50.0) | 17 (53.1) | |
| Female | 22 (47.8) | 7 (50.0) | 15 (46.9) | |
| Education, years | 0.94 | |||
| 1–9 | 18 (39.1) | 6 (42.9) | 12 (37.5) | |
| 10–12 | 10 (21.7) | 3 (21.4) | 7 (21.9) | |
| ≥13 | 18 (39.1) | 5 (35.7) | 13 (40.6) | |
| BMI, kg/m2 | 0.51 | |||
| Underweight | 4 (8.7) | 1 (7.1) | 3 (9.4) | |
| Normal | 24 (52.2) | 8 (57.1) | 16 (50.0) | |
| Overweight/obesity | 17 (37.0) | 4 (28.6) | 13 (40.6) | |
| Smoking status | 0.99 | |||
| Never | 41 (89.1) | 13 (92.9) | 28 (87.5) | |
| Ever or now | 5 (10.9) | 1 (7.1) | 4 (12.5) | |
| Physical activity | 0.23 | |||
| Never | 23 (50.0) | 6 (42.9) | 17 (53.1) | |
| Rare | 14 (30.4) | 3 (21.4) | 11 (34.4) | |
| Often | 9 (19.6) | 5 (35.7) | 4 (12.5) | |
| Alcohol consumption | 0.72 | |||
| Never | 32 (71.1) | 11 (78.6) | 21 (67.7) | |
| Rare or often | 13 (28.9) | 3 (21.4) | 10 (32.3) | |
| Chronic disease history | 0.65 | |||
| None | 40 (87.0) | 13 (92.9) | 27 (84.4) | |
| At least onea | 6 (13.0) | 1 (7.1) | 5 (15.6) | |
| Severity | 0.40 | |||
| Asymptomatic | 4 (8.7) | 2 (14.3) | 2 (6.3) | |
| Mild | 41 (89.1) | 12 (85.7) | 29 (90.6) | |
| Severe | 1 (2.2) | 0 (0.0) | 1 (3.1) | |
| Symptoms at administration | ||||
| Dry cough | 34 (81.0) | 11 (91.7) | 23 (76.7) | 0.40 |
| Fever | 29 (69.1) | 7 (58.3) | 22 (73.3) | 0.46 |
| Expectoration | 16 (38.1) | 6 (50.0) | 10 (33.3) | 0.48 |
| Headache | 8 (19.1) | 2 (16.7) | 6 (20.0) | 0.99 |
| Fatigue | 8 (19.1) | 2 (16.7) | 6 (20.0) | 0.65 |
| Pharyngalgia | 7 (16.7) | 3 (25.0) | 4 (13.3) | 0.39 |
| Chest pain | 3 (7.1) | 1 (8.3) | 2 (6.7) | 0.99 |
| Chest stuffiness | 3 (7.1) | 2 (16.7) | 1 (3.3) | 0.99 |
| Anorexia | 4 (9.5) | 0 (0.0) | 4 (13.3) | 0.31 |
| Myalgia | 3 (7.1) | 1 (8.3) | 2 (6.7) | 0.99 |
| Dizziness | 3 (7.1) | 2 (16.7) | 1 (3.3) | 0.19 |
| Diarrhea | 2 (4.8) | 2 (16.7) | 0 (0.0) | 0.08 |
| Nausea | 1 (2.4) | 0 (0.0) | 1 (3.3) | 0.99 |
| Rhinobyon | 1 (2.4) | 0 (0.0) | 1 (3.3) | 0.99 |
| Shortness of breath | 2 (2.4) | 0 (0.0) | 2 (6.7) | 0.99 |
| Chest CT findings | ||||
| Ground-glass opacity | 29 (63.0) | 7 (50.0) | 22 (68.8) | 0.23 |
| Bilateral patchy shadowing | 12 (26.1) | 5 (35.7) | 7 (21.9) | 0.47 |
| Consolidation | 6 (13.0) | 2 (14.3) | 4 (12.5) | 0.99 |
| Local patchy shadowing | 2 (4.4) | 0 (0.0) | 2 (6.3) | 0.99 |
a
The specific medical diseases included obesity (1), diabetes (1), chronic lung disease (1), hyperthyroidism (1), kidney stones (1), and arthrolithiasis (1).